Optimizing Biomarker Testing in Your Practice: Leveraging In-House Testing Strategies

EP. 11: Mitigating Socioeconomic Disparities Through Decentralized Testing: Overcoming Barriers to Access and Equity

February 10th 2025

Panelists discuss how decentralizing testing can address socioeconomic disparities by improving access to diagnostics for underserved populations. In-house testing reduces barriers like transportation challenges, lack of insurance, and limited availability of specialized tests, ensuring timely, equitable health care for all communities.

EP. 12: Key Takeaways and Future Perspectives for In-House Biomarker Testing

February 17th 2025

Panelists discuss how in this discussion the top 3 key points were patient-centric care, enhanced multidisciplinary coordination, and increased access and equity. In the next 3 to 5 years there will be more decentralized testing, potentially more practices participating in genomic profiling, the cost of testing will go down and the turnaround time will be shorter.